You have 9 free searches left this month | for more free features.

CGRP-antibodies

Showing 1 - 25 of 4,079

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

Recruiting
  • Migraine
  • +4 more
  • Innsbruck, Tirol, Austria
  • +2 more
Oct 19, 2022

Headache, Migraine Trial in Chicago, Naperville (Ubrogepant 50 MG [Ubrelvy], Ubrogepant 100 MG [Ubrelvy])

Not yet recruiting
  • Headache, Migraine
  • Ubrogepant 50 MG [Ubrelvy]
  • Ubrogepant 100 MG [Ubrelvy]
  • Chicago, Illinois
  • +1 more
Aug 14, 2022

Chronic Migraine Trial (KOS (Intranasal kinetic oscillation stimulation))

Not yet recruiting
  • Chronic Migraine
  • KOS (Intranasal kinetic oscillation stimulation)
  • (no location specified)
Apr 14, 2022

BIOmarkers of MIGraine:Proof of Concept Study Based on

Recruiting
  • Migraine
    • Hamburg, Germany
    • +2 more
    Apr 27, 2021

    Migraine, Migraine Without Aura, Migraine With Aura Trial in Glostrup (Erenumab, Placebo, Calcitonin gene-related peptide)

    Recruiting
    • Migraine
    • +2 more
    • Glostrup, Denmark
      Danish Headache Center
    Oct 6, 2020

    Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)

    Recruiting
    • Migraine
    • Head Pain
      • Valladolid, Spain
        Hospital Clínico Universitario de Valladolid
      Mar 23, 2023

      Migraine Trial in Glostrup (Eptinezumab, PACAP-38)

      Recruiting
      • Migraine
      • Glostrup, Denmark
        Danish headache center
      Dec 1, 2022

      Caused by Anti-CGRP mAbs in Migraine Patients Treated With

      Recruiting
      • Migraine Disorders
      • Diagnostic radiology
      • Lugano, Ticino, Switzerland
        Chiara ZECCA
      Sep 6, 2023

      Migraine Disorders, Chronic Migraine, Episodic Migraine Trial in Pavia (Monoclonal antibody targeting the CGRP pathway (ligand

      Recruiting
      • Migraine Disorders
      • +2 more
      • Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)
      • Pavia, Italy
        Headache Science & Neurorehabilitation Center
      Nov 23, 2023

      CGRP Inhibition, Autonomic Function, and Migraine

      Recruiting
      • Episodic Migraine
      • Chronic Migraine
      • Vienna, Austria
        Medical University of Vienna
      Apr 8, 2022

      New Persistent Daily Headache Trial (CGRP antibody)

      Not yet recruiting
      • New Persistent Daily Headache
      • CGRP antibody
      • (no location specified)
      Aug 29, 2023

      MIDAS Reduction at 3 Months for Erenumab Treatment

      Completed
      • Migraine
      • Erenumab 70/140 mg s.c.
      • Pavia, Italy
        Headache Science & Neurorehabilitation Center
      Jun 28, 2022

      Monoclonal Antibody Duration of REsponse in MIgraine After

      Recruiting
      • Migraine
      • Headache, Migraine
      • Headache calendar completion
      • Valladolid, Spain
        Hospital Clínico Universitario de Valladolid
      Jul 15, 2022

      Migraine Trial in Leuven (UB-313, Placebo)

      Recruiting
      • Migraine
      • UB-313
      • Placebo
      • Leuven, Belgium
        Katholieke Universiteit Leuven
      Jul 25, 2022

      Psychological and Biological Markers of Refractory Migraine

      Not yet recruiting
      • Migraine
        • Pavia, Italy
          Headache Science Center
        Sep 13, 2021

        Acute Treatment of Migraine With Rimegepant 75 mg

        Not yet recruiting
        • Migraine Disorders
        • Rimegepant 75 milligrams
        • Latina, Italy / Latina, Italy
          Sapienza University of Rome Polo Pontino - ICOT
        May 24, 2023

        New Daily Persistent Headache Biomarkers Study

        Terminated
        • New Daily Persistent Headache
        • New Daily Persistent Headache (NDPH)
          • Bronx, New York
            Montefiore Headache Center
          Feb 15, 2022

          Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

          Recruiting
          • Migraine
          • +3 more
          • Click Digital Therapeutic
          • New York, New York
            Click Therapeutics
          Aug 15, 2023

          Migraine Trial in L'Aquila (Blood sampling for microRNA testing)

          Recruiting
          • Migraine
          • Blood sampling for microRNA testing
          • L'Aquila, Italy
            University of L'Aquila
          Jul 1, 2021

          atoGepant In reaAl Life iN iTaly

          Not yet recruiting
          • Migraine, Prophylaxis
          • (no location specified)
          Nov 13, 2023

          Chronic Migraine Trial in Brookline (Emgality 120 MG in 1 ML Prefilled Syringe)

          Recruiting
          • Chronic Migraine
          • Emgality 120 MG in 1 ML Prefilled Syringe
          • Brookline, Massachusetts
            Pain Clinic at Beth Israel Deaconess Medical Center
          Mar 16, 2022

          Diabetic Polyneuropathy Trial in Rochester, Aarhus, Copenhagen (Eptinezumab, Placebo)

          Not yet recruiting
          • Diabetic Polyneuropathy
          • Rochester, Minnesota
          • +2 more
          Jun 30, 2023

          Migraine Using Enerumab and Traditional Therapy at Time of

          Completed
          • Migraine Disorders
          • Fayoum, Egypt
            Marwa Kamal Ahmed Tolba
          Sep 17, 2021

          Migraine Trial in Talavera De La Reina (Transcranial direct current stimulation (tDCS), anti-CGRP-mAbs)

          Completed
          • Migraine
          • Talavera De La Reina, Toledo, Spain
            Clinica de Intervencion en Neurociencias
          Oct 15, 2023

          Chronic Migraine Trial in Worldwide (Galcanezumab, Placebo)

          Recruiting
          • Chronic Migraine
          • Huntsville, Alabama
          • +82 more
          Dec 26, 2022